This Article Full Text Full Text (PDF) All Versions of this Article: 2006-0113OCv1 35/4/503    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brooks, A. M. Articles by Sedgwick, J. B. Search for Related Content PubMed PubMed Citation Articles by Brooks, A. M. Articles by Sedgwick, J. B.

Urokinase-Type Plasminogen Activator Modulates Airway Eosinophil Adhesion in Asthma

Allergy, Immunology and Pulmonary Unit, Department of Medicine, and Department of Biomolecular Chemistry, University of Wisconsin, Madison, Wisconsin

Correspondence and requests for reprints should be addressed to Julie B. Sedgwick, Ph.D., CSC-3244 H6/355 Allergy, 600 Highland Ave., Madison, WI 53792. E-mail: jxs{at}medicine.wisc.edu

Eosinophils migrate from the vascular circulation to the inflamed airways during asthma exacerbations. While the mechanism(s) of this process is not known, the expression of urokinase-type plasminogen activator receptor (uPAR) has been found to modulate neutrophil adhesion and migration to inflammatory sites. We hypothesized that increased expression of uPAR and its ligand, uPA, enhance eosinophil adhesion in patients with asthma. Patients with allergic asthma underwent segmental bronchoprovocation with allergen; 48 h later, peripheral blood and airway (from bronchoalveolar lavage fluid) eosinophils were isolated. uPA and uPAR protein expression were measured by flow cytometry and Western blot; mRNA was quantified by real-time PCR. Eosinophil adhesion to intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 was assessed by eosinophil peroxidase activity. Airway eosinophils expressed significantly more uPA and uPAR protein and uPAR mRNA than peripheral blood eosinophils. Removal of cell-bound uPA and/or addition of exogenous uPA had no effect on blood eosinophil adhesion to ICAM-1 or VCAM-1. In contrast, exogenous uPA stimulated ICAM and VCAM adhesion of airway eosinophils. N-formyl-methionyl-leucyl-phenylalanine–activated airway eosinophil adherence to VCAM-1 and ICAM-1 (VCAM-1, 52.8 ± 4.7%; ICAM-1, 49.2 ± 5.3%) was increased over blood eosinophil adhesion (VCAM-1, 38.4 ± 3.6%; ICAM-1, 27.7 ± 4.9%; P < 0.05). Removal of cell-bound uPA from airway eosinophils decreased adhesion to blood cell levels; reintroduction of exogenous uPA completely restored adhesion levels. These data suggest that constitutive uPA primes, and exogenous uPA can activate, airway eosinophil adhesion following segmental allergen challenge and that increased uPA expression may be a mechanism of increased eosinophil infiltration and function in asthma.

Key Words: adhesion • asthma • eosinophil • priming • urokinase-type plasminogen activator

This article has been cited by other articles:

				C. M. Swaisgood, M. A. Aronica, S. Swaidani, and E. F. Plow Plasminogen Is an Important Regulator in the Pathogenesis of a Murine Model of Asthma Am. J. Respir. Crit. Care Med., August 15, 2007; 176(4): 333 - 342. [Abstract] [Full Text] [PDF]

				P. Begin, K. Tremblay, D. Daley, M. Lemire, S. Claveau, C. Salesse, S. Kacel, A. Montpetit, A. Becker, M. Chan-Yeung, et al. Association of Urokinase-type Plasminogen Activator with Asthma and Atopy Am. J. Respir. Crit. Care Med., June 1, 2007; 175(11): 1109 - 1116. [Abstract] [Full Text] [PDF]